Shilpa Medicare’s equal joint venture with Zydus group - Oncosol - along with its partner company Shorla Oncology, has announced USFDA's approval for IMKELDI, the first oral liquid form of imatinib to ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) has been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, Marketbeat reports. Four equities ...

Tenax also is developing a unique oral formulation of imatinib. For more information, visit Tenax’s common stock is listed on The Nasdaq Stock Market LLC under the symbol “TENX”.